N@N

Market Maker Surveillance Report. SCLN, ORCC, FSS, EGLE, AOB, ECYT, Winning Stocks With Lowest Price Friction For Wednesday, M

March 14, 2012 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Wednesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Wednesday there were 3558 companies with "abnormal" market making, 1893 companies with positive Friction Factors and 4329 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Wednesday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. SciClone Pharmaceuticals Inc (NASDAQ:SCLN), ONLINE RESOURCES CORP (NASDAQ:ORCC), FEDERAL SIGNAL CORP (NYSE:FSS), EAGLE BULK SHIPPING INC (NASDAQ:EGLE), AMERICAN ORIENTAL BIOENGINEE (NYSE:AOB), ENDOCYTE INC (NASDAQ:ECYT). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

  Symbol  Change    Percent   Buy Volume   Buy %%    Sell Volume  Sell %%   Net Volume   Friction
  SCLN    $1.100    20.99%    1,853,968    50.66%    1,794,597    49.04%    59,371       540     
  ORCC    $0.620    21.23%    48,314       57.62%    35,536       42.38%    12,778       206     
  FSS     $1.200    26.20%    556,444      34.20%    492,645      30.28%    63,799       532     
  EGLE    $0.260    16.88%    1,192,199    51.43%    1,131,548    48.82%    60,651       2,333   
  AOB     $0.240    17.91%    376,262      37.05%    256,612      25.27%    119,650      4,985   
  ECYT    $2.210    59.41%    6,110,184    50.83%    5,858,180    48.73%    252,004      1,140   

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net buy volumes (buy volume, sell volume) and low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows SCLN with a dollar gain Wednesday of $1.10000 and a Friction Factor of 540 shares. That means that it only took 540 more shares of buying than selling to move SCLN higher by one penny. The Market Makers are currently allowing the stock to rise quickly (low friction). The combination of low friction and positive market direction can drive prices higher much faster than normal.

SciClone Pharmaceuticals Inc (NASDAQ:SCLN) - SciClone Pharmaceuticals, Inc. engages in the development and commercialization of therapeutics for the treatment of cancer and infectious diseases in the Peoples Republic of China and internationally. Its principal product is ZADAXIN for the treatment of hepatitis B and hepatitis C viruses, and certain cancers, as well as for use as a vaccine adjuvant or as a chemotherapy adjuvant for cancer patients with weakened immune systems. ZADAXIN has approval in approximately 30 countries, primarily in Asia, eastern Europe, the Middle East, and Latin America. The company markets and sells ZADAXIN principally through its distributors. It is also developing SCV-07, which is in phase 2 clinical trial for the treatment of oral mucositis and hepatitis C virus; and ZADAXIN (Thymalfasin), which completed phase 2 clinical trial for the treatment of stage IV melanoma. SciClone Pharmaceuticals also has commercialization rights for DC Bead, a product candidate for the treatment of advanced liver cancer in China, as well as for ondansetron RapidFilm, an oral thin film formulation of ondansetron to treat and prevent nausea and vomiting caused by chemotherapy, radiotherapy, and surgery in China and Vietnam. The company was founded in 1989 and is headquartered in Foster City, California.

ONLINE RESOURCES CORP (NASDAQ:ORCC) - Online Resources Corporation provides outsource and Web-and phone-based financial technology services to financial institution, biller, card issuer, and creditor clients in the United States. The company offers an integrated suite of Web-based account presentation, payment, relationship management, and professional services. Its account presentation services enable in viewing transaction histories and account balances; reviewing and retrieving current and past statements; transferring funds and balances; initiating or scheduling either one-time or recurring payments; accessing and maintaining account information; and providing cash management services. The companys payments services comprise Web-based bill payment services, remittance services, a suit of payment options, and real-time account debit services. Its relationship management services consist of customer care services; and professional services comprise customized software applications, such as account opening and lending for financial institution clients, which enable them to acquire consumers via the Web channel; implementation services that convert existing data and integrate with the clients legacy host system or third party core processor; ongoing maintenance of client specific applications or interfaces; and customization of applications, training of client personnel, and information reporting and analysis. The companys third party services include bill payment and account retrieval, check ordering, inter-institution funds transfer and account aggregation, check imaging, and electronic statement services. Online Resources Corporation was founded in 1989 and is headquartered in Chantilly, Virginia.

FEDERAL SIGNAL CORP (NYSE:FSS) - Federal Signal Corporation designs and manufactures a suite of products and integrated solutions for municipal, governmental, industrial, and commercial customers worldwide. The company operates in three segments: Safety and Security Systems, Fire Rescue, and Environmental Solutions. The Safety and Security Systems segment offers various systems for automated license plate recognition, campus and community alerting, emergency vehicles, first responder interoperable communications, industrial communications and command, municipal networked security, vehicle classification, parking revenue, and access control. This segment also provides products, such as lightbars and sirens, public warning sirens, and public safety software. The Fire Rescue segment offers articulated and telescopic aerial platforms for rescue, fire fighting, and maintenance purposes. This segment sells its products to municipal and industrial fire services, civil defense authorities, rental companies, electric utilities and industrial customers. The Environmental Solutions segment provides various self-propelled street cleaning vehicles, vacuum loader vehicles, municipal catch basin/sewer cleaning vacuum trucks, and water blasting equipment. The company was founded in 1901 and is based in Oak Brook, Illinois.

EAGLE BULK SHIPPING INC (NASDAQ:EGLE) - Eagle Bulk Shipping Inc. engages in the ocean transportation of bulk cargoes in the dry bulk industry. The company primarily transports iron ore, coal, grain, cement, and fertilizer along worldwide shipping routes. As of December 31, 2009, it owned and operated a fleet of 27 oceangoing vessels with a combined carrying capacity of 1,412,535 deadweight tons. The company was founded in 2005 and is headquartered in New York, New York.

AMERICAN ORIENTAL BIOENGINEE (NYSE:AOB) - American Oriental Bioengineering, Inc. engages in the development, manufacture, and commercialization of a range of pharmaceutical and healthcare products. The companys principal prescription pharmaceutical products include Shuanghuanglian Lyophilized Injection Powder (SHL Injection Powder), an anti-viral injection for treating respiratory infections, bronchitis, and tonsillitis; and Cease Enuresis Soft Gel (CE Gel) that is used to alleviate bedwetting. Its over-the-counter pharmaceutical products include Jinji Series, a line of products approved for the treatment of various womens health indications, including endometritis, annexitis, pelvic inflammation, and premenstrual and menopausal symptoms; Jinji Yimucao, which is used for the treatment of premenstrual syndrome and other PMS and menopause-related symptoms; Cease Enuresis Patch, a product indicated to alleviate bedwetting and for the treatment of incontinence; and Boke Series, a line of nasal products indicated to alleviate sinus infections and nasal congestions. The company also markets various nutraceutical products, such as soybean peptide based drinks, tablets, powder, and instant coffee. American Oriental Bioengineering sells its products primarily to hospitals, clinics, pharmacies, and retail outlets in China through its sales professionals and distributors. The company is based in Beijing, China.

ENDOCYTE INC (NASDAQ:ECYT) - Endocyte, Inc., a biopharmaceutical company, develops targeted therapies for the treatment of cancer and inflammatory diseases. The company utilizes its proprietary technology to create novel small molecule drug conjugates, or SMDCs, and companion imaging diagnostics. Its SMDCs actively target receptors that are over-expressed on diseased cells, relative to healthy cells. The companys products include EC145, a Phase II clinical trial product that targets platinum-resistant ovarian cancer and non-small cell lung cancer; EC0489 and EC0225, which are Phase I clinical trial products for the treatment for solid tumors; EC17 targeting solid tumors has concluded the enrollment in Phase I clinical trial; and EC0531 and EC1069 that are under preclinical trials for the treatment of solid tumors and prostate cancer. Its products also comprise EC0746 and EC0565, which are under preclinical trials targeting inflammation. In addition, Endocytes companion diagnostic products consist of EC20, a folate-targeted molecular imaging agent that is being developed to identify in a non-invasive manner tumors is under Phase II clinical trial; and EC0652 that is under preclinical trials targets an imaging agent to receptors over-expressed on prostate cancer. The company was founded in 1995 and is based in West Lafayette, Indiana.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net